Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech

3.60
-0.1100-2.96%
Post-market: 3.58-0.0200-0.56%17:06 EDT
Volume:2.41M
Turnover:8.78M
Market Cap:107.12M
PE:-1.64
High:3.90
Open:3.81
Low:3.49
Close:3.71
52wk High:3.90
52wk Low:1.33
Shares:29.75M
Float Shares:21.69M
Volume Ratio:0.96
T/O Rate:11.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1959
EPS(LYR):-2.6890
ROE:-784.32%
ROA:-40.94%
PB:2.44
PE(LYR):-1.34

Loading ...

Someone let AI fully-control their stock portfolio: here's how it did

Switzer
·
Yesterday

Fortress Biotech Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 21

Fortress Biotech Q2 EPS $0.45 Beats $(0.36) Estimate, Sales $16.413M Beat $14.534M Estimate

Benzinga
·
Aug 15

Fortress Biotech Reports Q2 2025 Revenue Increase to $16.4M, Dermatology Sales Lead Growth

Reuters
·
Aug 15

Fortress Biotech Q2 Net Income USD -11.654 Million

THOMSON REUTERS
·
Aug 15

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

GlobeNewswire
·
Aug 15

Press Release: Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Dow Jones
·
Aug 13

Fortress Biotech Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
Aug 08

Mustang Bio Inc. Secures FDA Orphan Drug Designation for MB-101 to Treat Astrocytomas and Glioblastoma

Reuters
·
Jul 09

BUZZ-Mustang soars on FDA's orphan drug tag for brain cancer therapy

Reuters
·
Jul 08

BUZZ-U.S. STOCKS ON THE MOVE-U.S. Bancorp, IonQ, BlackRock

Reuters
·
Jul 08

Fortress Biotech Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 23

Fortress Biotech Inc. Reports Significant Turnaround with Net Loss Converted to $14.999M Profit; EPS Jumps to $0.57

Reuters
·
Jun 06

Press Release: Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

Dow Jones
·
May 30

Checkpoint Therapeutics Inc. Announces April 2025 Agreement for Merger with Sun Pharmaceutical's Subsidiary

Reuters
·
May 30

Checkpoint Therapeutics Inc. Held Virtual Special Meeting on Merger Proposals

Reuters
·
May 29

Checkpoint Therapeutics Inc. Sets May 30, 2025, as Expected Closing Date for Merger with Sun Pharmaceutical Industries

Reuters
·
May 22

Avenue Therapeutics Inc. Reports Q1 Loss from Operations of $1.905M, Decrease from $3.708M in Prior Year

Reuters
·
May 21

Fortress Biotech Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
May 17

Fortress Biotech Q1 EPS $(0.48) Beats $(0.49) Estimate, Sales $13.14M Beat $11.62M Estimate

Benzinga
·
May 16